Efficacy and Safety of GPR119 Agonist DS-8500a in Japanese Patients with Type 2 Diabetes: a Randomized, Double-Blind, Placebo-Controlled, 12-Week Study

Overview of attention for article published in Advances in Therapy, February 2018

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (62nd percentile)
Above-average Attention Score compared to outputs of the same age and source (58th percentile)

So far, Altmetric has seen 6 X posts from 6 X users, with an upper bound of 36,447 followers.

GPR119 Agonist DS-8500a inferior to sitagliptin for #diabetes from baseline A1c ~8% Yamada et al Adv Ther https://t.co/X6b7sjnBUl https://t.co/jWV4rrIJgS

RT @DanielJDrucker: Does GPR119 have enough therapeutic gas in the tank to make it through clinical development #diabetes https://t.co/Wvgi…

RT @DanielJDrucker: Does GPR119 have enough therapeutic gas in the tank to make it through clinical development #diabetes https://t.co/Wvgi…

RT @DanielJDrucker: Does GPR119 have enough therapeutic gas in the tank to make it through clinical development #diabetes https://t.co/Wvgi…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 2 additional X posts.